B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Osimertinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Osimertinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rociletinib
5 shared targets
tolebrutinib
3 shared targets
acalabrutinib
4 shared targets
poziotinib
4 shared targets
icotinib
3 shared targets
canertinib
3 shared targets
tucatinib
3 shared targets
zanubrutinib
4 shared targets
tirabrutinib
3 shared targets
asp
7 shared targets
Loading evidence profile...

This evidence profile for Osimertinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.